T

Terray Therapeutics, Inc.

Generative AI-powered small-molecule drug discovery platform

Principal Scientist - Protein Biochemistry and Structural Biology

Translational Research & Bench BiologyUpdated on Nov 14
Full-timeMonrovia, CA, USA$180k - $263k /yr

About the Job

Requirements

  • A PhD in Structural Biology, Biochemistry, Biophysics, or a related field, and at least 10 years of additional experience.
  • Extensive protein purification experience, ideally including construct design, expression, and purification in multiple systems such as E. coli, insect, and mammalian systems, and experience investigating a broad range of protein families.
  • Experience using structural biology and protein structure/function to evaluate novel drug targets and small-molecule binding.
  • Ability to work in a multidisciplinary, matrixed environment across multiple concurrent projects and programs.
  • Strong organizational, communication, and interpersonal skills.

Responsibilities

  • Use structural biology expertise to guide protein construct design and purification strategy across programs, and assess current and future crystallography needs to enable programs or validate targets.
  • Partner with scientists in biology, chemistry, platform, screening, data, and computational teams to determine and correctly implement construct and purified-protein needs.
  • Manage relationships and protein needs for partnerships across a network of contract research organizations.
  • Guide protein quality control and stability investigations of purified protein material to ensure consistency across assays and platform data.
  • Build effective protein management and organization workflows.
  • Maintain and manage protein inventory and registration within Benchling.
  • Apply protein design to assay development, including biochemical and biophysical assays.

Desired Qualifications

  • Hands-on structural biology experience, preferably using X-ray crystallography and/or cryo-electron microscopy and accompanying software to investigate, analyze, and assess small-molecule binding to a target of interest.

About the Company

Terray Therapeutics, Inc.

Generative AI-powered small-molecule drug discovery platform

Terray Therapeutics combines wet-lab experimentation with AI to discover small molecule drugs. It builds a data-driven platform that collects over two billion target–ligand binding measurements, adding about 150 million per month, to train deep learning models that predict molecular properties. Its rapid design-make-test-analyze cycle takes under a month per target, allowing millions of molecules to be measured and enabling the identification of potent, selective compounds across many targets. With a focus on immunology and partnerships with pharmaceutical and biotech companies, Terray pursues internal programs and collaborations to accelerate discovery of safe, effective small molecules.

Company size
51-200
Company stage
Series B
Total funding
$195M
Headquarters
Pasadena, CA
Founded
2018

Recently Posted Jobs

Explore more opportunities at Terray Therapeutics, Inc.

See more jobs